BUPRENORPHINE-NALOXONE 2-0.5 MG SL TABLET

Buprenorphine and Naloxone
$0.4698per EA
DEA Schedule CIII

Strength

2; .5 mg/1; mg/1

NDC

62175045232

Classification

Generic

Dosage Form

TABLET

Route

SUBLINGUAL

Last Updated

4/22/2026

Active Ingredients

BUPRENORPHINE; NALOXONE

Approval Type

Generic (ANDA)

FDA Application

ANDA205022

On Market Since

9/19/2016

Pharmacological Classes

Opioid Antagonist
Opioid Antagonists
Partial Opioid Agonist
Partial Opioid Agonists

Price History

1W

0.0%

1M

-2.4%

3M

-0.0%

6M

-5.2%

1Y

-5.6%

3Y

-13.9%

5Y

-53.9%

All

-69.3%